Atlas Trials

A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001

Clinical trial NCT01559818 · TERMINATED

Trial details

NCT number
NCT01559818
Sponsor
Immodulon Therapeutics Ltd
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2012-02-01
Primary completion
2019-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.